Tesamorelin/Ipamorelin 11/6 mg

The Tesamorelin and Ipamorelin blend is a synthetic peptide combination developed for research use to investigate synergistic modulation of the growth hormone (GH) axis through distinct yet complementary mechanisms. Tesamorelin is a 44-amino-acid growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is a selective pentapeptide ghrelin receptor agonist. Together, they are studied for enhanced GH secretion, metabolic regulation, and tissue regeneration in preclinical and laboratory models.

Research involving the Tesamorelin and Ipamorelin blend commonly explores:

• Dual activation of the pituitary gland via GHRH receptor stimulation (Tesamorelin) and ghrelin receptor (GHS-R1a) agonism (Ipamorelin), amplifying endogenous GH release.
• Potential improvements in body composition, including lean muscle mass increase and visceral fat reduction.
• Effects on metabolic function including insulin sensitivity, lipid profile modulation, and glucose homeostasis.
• Investigations into cognitive benefits through neuroplasticity, synaptic function, and enhanced neurotrophic factor expression.
• Support of regenerative processes such as tissue repair, anti-aging, and anabolic recovery.
The Tesamorelin and Ipamorelin blend is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: Tesamorelin (3E)-hex-3-enoylsomatoliberin, Ipamorelin (Aib-His-D-2Nal-D-Phe-Lys-NH2)
• Purity: ≥98%
• Molecular Weight: Tesamorelin ~5136 Da; Ipamorelin ~711.8 Da
• Molecular Formula: Tesamorelin C221H366N72O67S; Ipamorelin C38H49N9O5
• Appearance: White to off-white lyophilized powder mix

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.